These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 14619899)
1. Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count. Prescrire Int; 2003 Oct; 12(67):183. PubMed ID: 14619899 [No Abstract] [Full Text] [Related]
2. [Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?]. Wautrecht JC J Mal Vasc; 2011 Feb; 36(1):1-2. PubMed ID: 21146338 [No Abstract] [Full Text] [Related]
3. [Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?]. Lambert M; Trillot N; Cooren G; Glantenet R; Jude B; Hatron PY J Mal Vasc; 2010 Dec; 35(6):348-51. PubMed ID: 20888159 [TBL] [Abstract][Full Text] [Related]
4. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals. Spinler SA Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223 [TBL] [Abstract][Full Text] [Related]
5. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). Rota E; Bazzan M; Fantino G Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338 [No Abstract] [Full Text] [Related]
10. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature]. Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252 [TBL] [Abstract][Full Text] [Related]
11. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis. Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278 [TBL] [Abstract][Full Text] [Related]
12. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU. Warkentin TE; Cook DJ Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671 [TBL] [Abstract][Full Text] [Related]
14. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229 [TBL] [Abstract][Full Text] [Related]
15. Heparins, low-molecular-weight heparins, and pentasaccharides. Dinwoodey DL; Ansell JE Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine. Mattioli AV Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651 [TBL] [Abstract][Full Text] [Related]
17. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Bryant A; Low J; Austin S; Joseph JE Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016 [TBL] [Abstract][Full Text] [Related]